U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.839G>A (p.Arg280Lys) AND Li-Fraumeni syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 19, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000633356.8

Allele description [Variation Report for NM_000546.6(TP53):c.839G>A (p.Arg280Lys)]

NM_000546.6(TP53):c.839G>A (p.Arg280Lys)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.839G>A (p.Arg280Lys)
HGVS:
  • NC_000017.11:g.7673781C>T
  • NG_017013.2:g.18770G>A
  • NM_000546.6:c.839G>AMANE SELECT
  • NM_001126112.3:c.839G>A
  • NM_001126113.3:c.839G>A
  • NM_001126114.3:c.839G>A
  • NM_001126115.2:c.443G>A
  • NM_001126116.2:c.443G>A
  • NM_001126117.2:c.443G>A
  • NM_001126118.2:c.722G>A
  • NM_001276695.3:c.722G>A
  • NM_001276696.3:c.722G>A
  • NM_001276697.3:c.362G>A
  • NM_001276698.3:c.362G>A
  • NM_001276699.3:c.362G>A
  • NM_001276760.3:c.722G>A
  • NM_001276761.3:c.722G>A
  • NP_000537.3:p.Arg280Lys
  • NP_000537.3:p.Arg280Lys
  • NP_001119584.1:p.Arg280Lys
  • NP_001119585.1:p.Arg280Lys
  • NP_001119586.1:p.Arg280Lys
  • NP_001119587.1:p.Arg148Lys
  • NP_001119588.1:p.Arg148Lys
  • NP_001119589.1:p.Arg148Lys
  • NP_001119590.1:p.Arg241Lys
  • NP_001263624.1:p.Arg241Lys
  • NP_001263625.1:p.Arg241Lys
  • NP_001263626.1:p.Arg121Lys
  • NP_001263627.1:p.Arg121Lys
  • NP_001263628.1:p.Arg121Lys
  • NP_001263689.1:p.Arg241Lys
  • NP_001263690.1:p.Arg241Lys
  • LRG_321t1:c.839G>A
  • LRG_321:g.18770G>A
  • LRG_321p1:p.Arg280Lys
  • NC_000017.10:g.7577099C>T
  • NM_000546.4:c.839G>A
  • NM_000546.5:c.839G>A
Protein change:
R121K
Links:
dbSNP: rs121912660
NCBI 1000 Genomes Browser:
rs121912660
Molecular consequence:
  • NM_000546.6:c.839G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.839G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.839G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.839G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126115.2:c.443G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126116.2:c.443G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126117.2:c.443G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.722G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.722G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.722G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276697.3:c.362G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276698.3:c.362G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276699.3:c.362G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.722G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.722G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Li-Fraumeni syndrome (LFS)
Synonyms:
Sarcoma family syndrome of Li and Fraumeni
Identifiers:
MONDO: MONDO:0018875; MedGen: C0085390; OMIM: PS151623

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000754578Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 19, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.

Zhou XP, Sanson M, Hoang-Xuan K, Robin E, Taillandier L, He J, Mokhtari K, Cornu P, Delattre JY, Thomas G, Hamelin R.

Ann Neurol. 1999 Dec;46(6):913-6.

PubMed [citation]
PMID:
10589545

The genomic landscape of hypodiploid acute lymphoblastic leukemia.

Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, Churchman M, Andersson A, Chen SC, McCastlain K, Becksfort J, Ma J, Wu G, Patel SN, Heatley SL, Phillips LA, Song G, Easton J, Parker M, Chen X, Rusch M, et al.

Nat Genet. 2013 Mar;45(3):242-52. doi: 10.1038/ng.2532. Epub 2013 Jan 20.

PubMed [citation]
PMID:
23334668
PMCID:
PMC3919793
See all PubMed Citations (8)

Details of each submission

From Invitae, SCV000754578.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 280 of the TP53 protein (p.Arg280Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with acute lymphoblastic leukemia, breast cancer, and/or glioblastoma (PMID: 10589545, 23334668; Invitae). ClinVar contains an entry for this variant (Variation ID: 376657). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 12826609, 29979965, 30224644) indicates that this missense variant is expected to disrupt TP53 function. Experimental studies have shown that this missense change affects TP53 function (PMID: 12826609, 20128691, 21343334). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 12, 2024